FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056998303> ?p ?o ?g. }

• W2056998303 endingPage "50" @default.
• W2056998303 startingPage "43" @default.
• W2056998303 abstract "Background/Aims: While the CA 125 and SCC antigens are used as tumor markers for ovarian cancer and uterine cervical cancer, respectively, an effective marker for uterine corpus cancer has not been identified. We asked whether β1,3-galactosyltransferase-4 and/or 5 (β3Gal-T4/T5) could serve as novel tumor markers for detecting gynecological carcinomas, especially those of the uterine corpus. Methods: We obtained a monoclonal antibody and a polyclonal antiserum against β3Gal-T5 and constructed a sandwich ELISA method. Western blot analysis and immunoprecipitation revealed that this ELISA recognizes both β3Gal-T4 and β3Gal-T5. Results: We found β3Gal-T4 and T5 enzymatic activity in ovarian cancer tissues, indicating that these enzymes are expressed at least in ovarian cancer. The cutoff value was determined by ROC analysis to be 5.4 ng/ml in the sera. The β3Gal-T4/T5-positive rates for the sera from ovarian cancer and uterine cervical cancer patients were comparable with the CA 125- and SCC antigen-positive rates for these cancers, respectively. Significantly, the β3Gal-T4/T5-positive rate was higher for uterine corpus cancer (64%) than the CA 125 (37%)- and CA 19-9 (24%)-positive rates. The stage I uterine corpus cancers had particularly high β3Gal-T4/T5-positive rates (57%). Conclusion: β3Gal-T4/T5 is a novel tumor marker for uterine corpus cancer and other gynecological cancers." @default.
• W2056998303 created "2016-06-24" @default.
• W2056998303 creator A5002129387 @default.
• W2056998303 creator A5013258133 @default.
• W2056998303 creator A5038177621 @default.
• W2056998303 creator A5056039415 @default.
• W2056998303 creator A5056431628 @default.
• W2056998303 creator A5073687228 @default.
• W2056998303 creator A5080871072 @default.
• W2056998303 creator A5081266641 @default.
• W2056998303 date "2009-01-01" @default.
• W2056998303 modified "2023-10-06" @default.
• W2056998303 title "&beta;1,3-Galactosyltransferases-4/5 Are Novel Tumor Markers for Gynecological Cancers" @default.
• W2056998303 cites W1512694863 @default.
• W2056998303 cites W1522206763 @default.
• W2056998303 cites W1547010638 @default.
• W2056998303 cites W1969162232 @default.
• W2056998303 cites W1973051352 @default.
• W2056998303 cites W1978246084 @default.
• W2056998303 cites W1984917863 @default.
• W2056998303 cites W2001797845 @default.
• W2056998303 cites W2026265540 @default.
• W2056998303 cites W2053088231 @default.
• W2056998303 cites W2074146726 @default.
• W2056998303 cites W2080368502 @default.
• W2056998303 cites W2102719470 @default.
• W2056998303 cites W2118593014 @default.
• W2056998303 cites W2127449110 @default.
• W2056998303 cites W2139705050 @default.
• W2056998303 cites W2146743052 @default.
• W2056998303 cites W2149515957 @default.
• W2056998303 cites W2150087209 @default.
• W2056998303 cites W2151527385 @default.
• W2056998303 cites W2276877803 @default.
• W2056998303 cites W2405247624 @default.
• W2056998303 cites W2604897152 @default.
• W2056998303 cites W97747682 @default.
• W2056998303 doi "https://doi.org/10.1159/000203129" @default.
• W2056998303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19225246" @default.
• W2056998303 hasPublicationYear "2009" @default.
• W2056998303 type Work @default.
• W2056998303 sameAs 2056998303 @default.
• W2056998303 citedByCount "18" @default.
• W2056998303 countsByYear W20569983032013 @default.
• W2056998303 countsByYear W20569983032014 @default.
• W2056998303 countsByYear W20569983032015 @default.
• W2056998303 countsByYear W20569983032017 @default.
• W2056998303 countsByYear W20569983032018 @default.
• W2056998303 countsByYear W20569983032019 @default.
• W2056998303 countsByYear W20569983032021 @default.
• W2056998303 countsByYear W20569983032022 @default.
• W2056998303 countsByYear W20569983032023 @default.
• W2056998303 crossrefType "journal-article" @default.
• W2056998303 hasAuthorship W2056998303A5002129387 @default.
• W2056998303 hasAuthorship W2056998303A5013258133 @default.
• W2056998303 hasAuthorship W2056998303A5038177621 @default.
• W2056998303 hasAuthorship W2056998303A5056039415 @default.
• W2056998303 hasAuthorship W2056998303A5056431628 @default.
• W2056998303 hasAuthorship W2056998303A5073687228 @default.
• W2056998303 hasAuthorship W2056998303A5080871072 @default.
• W2056998303 hasAuthorship W2056998303A5081266641 @default.
• W2056998303 hasConcept C111683008 @default.
• W2056998303 hasConcept C118646709 @default.
• W2056998303 hasConcept C121608353 @default.
• W2056998303 hasConcept C126322002 @default.
• W2056998303 hasConcept C143998085 @default.
• W2056998303 hasConcept C144369459 @default.
• W2056998303 hasConcept C147483822 @default.
• W2056998303 hasConcept C159654299 @default.
• W2056998303 hasConcept C203014093 @default.
• W2056998303 hasConcept C2778220009 @default.
• W2056998303 hasConcept C2778515176 @default.
• W2056998303 hasConcept C2780210213 @default.
• W2056998303 hasConcept C2780427987 @default.
• W2056998303 hasConcept C2781447364 @default.
• W2056998303 hasConcept C530470458 @default.
• W2056998303 hasConcept C542903549 @default.
• W2056998303 hasConcept C71924100 @default.
• W2056998303 hasConcept C91523082 @default.
• W2056998303 hasConcept C956191 @default.
• W2056998303 hasConceptScore W2056998303C111683008 @default.
• W2056998303 hasConceptScore W2056998303C118646709 @default.
• W2056998303 hasConceptScore W2056998303C121608353 @default.
• W2056998303 hasConceptScore W2056998303C126322002 @default.
• W2056998303 hasConceptScore W2056998303C143998085 @default.
• W2056998303 hasConceptScore W2056998303C144369459 @default.
• W2056998303 hasConceptScore W2056998303C147483822 @default.
• W2056998303 hasConceptScore W2056998303C159654299 @default.
• W2056998303 hasConceptScore W2056998303C203014093 @default.
• W2056998303 hasConceptScore W2056998303C2778220009 @default.
• W2056998303 hasConceptScore W2056998303C2778515176 @default.
• W2056998303 hasConceptScore W2056998303C2780210213 @default.
• W2056998303 hasConceptScore W2056998303C2780427987 @default.
• W2056998303 hasConceptScore W2056998303C2781447364 @default.
• W2056998303 hasConceptScore W2056998303C530470458 @default.
• W2056998303 hasConceptScore W2056998303C542903549 @default.
• W2056998303 hasConceptScore W2056998303C71924100 @default.
• W2056998303 hasConceptScore W2056998303C91523082 @default.

• next